journal article·2025-01-08

Biomimetic Anisotropic-Functionalized Platelet-Membrane-Coated Polymeric Particles for Targeted Drug Delivery to Human Breast Cancer Cells

Hongzhe Yu, Elana Ben-Akiva, Randall A. Meyer, Jordan J. Green

Publisher page

Abstract

Biomimetic particles that can replicate aspects of natural biological cell function are useful for advanced biological engineering applications. Engineering such particles requires mimicking the chemical complexity of the surface of biological cells, and this can be achieved by coating synthetic particles with naturally derived cell membranes. Past research has demonstrated the feasibility of utilizing cell membrane coatings from a variety of cell types to achieve extended blood circulation half-life. A particle’s shape can also be designed to mimic a biological cell or virus, and this physical attribute can cause particular transport and biodistribution properties. However, the potential synergy between engineering a biomimetic particle’s core shape in combination with functionalizing its surface with cell membranes to achieve targeted drug delivery has not been well-investigated. Here, anisotropic poly(lactic- co -glycolic acid) (PLGA) particles are coated with platelet membranes to engineer particles with enhanced stealth properties that are biomimetic in size, shape, and surface composition to natural platelets. The natural ability of platelets to target tumor cells was harnessed to develop a particulate system for targeted dual delivery of a small molecule and protein to cancer cells. The particles had targeted binding to metastatic human breast cancer cells, leading to enhanced killing of these cells in a mouse model through codelivery of TRAIL and doxorubicin. This system can be used for cancer cell killing and could potentially be utilized in preventing breast cancer metastasis. By engineering both the physical and chemical properties of the particles, biomimicry and therapeutic promise can be best achieved.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins Translational ImmunoEngineering Center, and the Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N. Broadway, Smith Building 5017, Baltimore, Maryland 21231, United States

Departments of Oncology, Ophthalmology, and Neurosurgery, Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, 400 N. Broadway, Smith Building 5017, Baltimore, Maryland 21231, United States

Departments of Materials Science and Engineering and Chemical and Biomolecular Engineering, Johns Hopkins University, 400 N. Broadway, Smith Building 5017, Baltimore, Maryland 21231, United States

Funding

National Cancer Institute · National Institute of Biomedical Imaging and Bioengineering

References (58)

Show source-provided references
1. 10.1002/adhm.20120013810.1002/adhm.201200138 ↗
2. 10.1021/acsnano.3c0028810.1021/acsnano.3c00288 ↗
3. 10.1126/sciadv.aaz610810.1126/sciadv.aaz6108 ↗
4. 10.1002/advs.20190330110.1002/advs.201903301 ↗
5. 10.1002/adma.20180223310.1002/adma.201802233 ↗
6. 10.1021/acs.nanolett.1c0016810.1021/acs.nanolett.1c00168 ↗
7. 10.1002/adfm.20210360010.1002/adfm.202103600 ↗
8. 10.1126/sciadv.aay903510.1126/sciadv.aay9035 ↗
9. 10.1021/nl500618u10.1021/nl500618u ↗
10. 10.1016/j.biomaterials.2015.10.04610.1016/j.biomaterials.2015.10.046 ↗
11. 10.1038/nmat234410.1038/nmat2344 ↗
12. 10.1021/nn200365a10.1021/nn200365a ↗
13. 10.1016/j.jconrel.2009.10.01410.1016/j.jconrel.2009.10.014 ↗
14. 10.1038/nnano.2007.7010.1038/nnano.2007.70 ↗
15. 10.1002/smll.20110200210.1002/smll.201102002 ↗
16. 10.1021/nl403949h10.1021/nl403949h ↗
17. 10.1002/smll.20140236910.1002/smll.201402369 ↗
18. 10.1016/j.actbio.2023.02.02310.1016/j.actbio.2023.02.023 ↗
19. 10.1371/journal.pcbi.100589910.1371/journal.pcbi.1005899 ↗
20. 10.1053/hp.2000.669810.1053/hp.2000.6698 ↗
21. 10.1126/science.120354310.1126/science.1203543 ↗
22. 10.1023/A:100676382788210.1023/A:1006763827882 ↗
23. 10.1182/blood.V96.10.330210.1182/blood.V96.10.3302 ↗
24. 10.1126/science.276.5309.11110.1126/science.276.5309.111 ↗
25. 10.1016/j.omto.2021.04.00410.1016/j.omto.2021.04.004 ↗
26. 10.1016/1074-7613(95)90057-810.1016/1074-7613(95)90057-8 ↗
27. 10.1073/pnas.03054509710.1073/pnas.030545097 ↗
28. 10.1186/bcr364510.1186/bcr3645 ↗
29. 10.1038/onc.2012.16410.1038/onc.2012.164 ↗
30. 10.3791/58332-v10.3791/58332-v ↗
31. 10.1073/pnas.070532610410.1073/pnas.0705326104 ↗
32. 10.1002/jbm.a.3539910.1002/jbm.a.35399 ↗
33. 10.1038/nature1537310.1038/nature15373 ↗
34. 10.1021/acsami.0c1995510.1021/acsami.0c19955 ↗
35. 10.1016/j.biomaterials.2016.11.03810.1016/j.biomaterials.2016.11.038 ↗
36. 10.1016/j.biomaterials.2013.09.05010.1016/j.biomaterials.2013.09.050 ↗
37. 10.1007/s11095-011-0436-310.1007/s11095-011-0436-3 ↗
38. 10.1002/adma.20120293210.1002/adma.201202932 ↗
39. 10.1007/s12265-012-9445-910.1007/s12265-012-9445-9 ↗
40. 10.1016/j.actbio.2018.03.05610.1016/j.actbio.2018.03.056 ↗
41. 10.1002/adma.20150332310.1002/adma.201503323 ↗
42. 10.1158/1078-0432.CCR-09-244310.1158/1078-0432.CCR-09-2443 ↗
43. 10.1186/1471-2407-5-210.1186/1471-2407-5-2 ↗
44. 10.1007/s10495-007-0081-910.1007/s10495-007-0081-9 ↗
45. 10.1016/j.biopha.2017.09.05910.1016/j.biopha.2017.09.059 ↗
46. Khemani M. · Ann. Biol. Res. · 2012 · 3 · 4414
47. 10.3390/pharmaceutics1212116510.3390/pharmaceutics12121165 ↗
48. 10.1126/science.288.5473.205110.1126/science.288.5473.2051 ↗
49. 10.1126/science.122956810.1126/science.1229568 ↗
50. 10.1016/j.jconrel.2010.07.11610.1016/j.jconrel.2010.07.116 ↗
51. 10.1038/nature0379910.1038/nature03799 ↗
52. 10.1038/nature1575610.1038/nature15756 ↗
53. 10.1160/TH11-08-059210.1160/TH11-08-0592 ↗
54. 10.1038/sj.bjp.070601310.1038/sj.bjp.0706013 ↗
55. 10.1038/nrmicro142510.1038/nrmicro1425 ↗
56. 10.1007/s11051-019-4580-810.1007/s11051-019-4580-8 ↗
57. 10.1016/j.actbio.2018.09.01710.1016/j.actbio.2018.09.017 ↗
58. 10.1016/j.cej.2019.12284810.1016/j.cej.2019.122848 ↗